Mark A Cervinski
Overview
Explore the profile of Mark A Cervinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walsh M, Kelliher M, Hubbard J, Cervinski M
J Appl Lab Med
. 2025 Feb;
PMID: 39903694
Background: Immunoassay drug screens provide rapid analysis of urine for the presence of therapeutics and drugs of abuse. Compared to definitive (confirmatory) methods, immunoassays are prone to false-positive and -negative...
2.
3.
4.
Cervinski M, Bietenbeck A, Katayev A, Loh T, van Rossum H, Badrick T
Adv Clin Chem
. 2023 Nov;
117:223-261.
PMID: 37973321
Patient-Based Real-Time Quality Control involves monitoring an assay using patient samples rather than external material. If the patient population does not change, then a shift in the long-term assay population...
5.
Walsh M, Cervinski M, Geno K
Clin Chem
. 2023 Oct;
69(10):1204-1205.
PMID: 37783661
No abstract available.
6.
Geno K, Cervinski M
J Mass Spectrom Adv Clin Lab
. 2023 Feb;
28:63-66.
PMID: 36846026
Background: Our laboratory historically performed immunosuppressant and definitive opioid testing in-house as laboratory developed (LDT) mass spectrometry-based tests. However, staffing constraints and supply chain challenges associated with the COVID-19 pandemic...
7.
Nerenz R, Hubbard J, Cervinski M
Clin Lab Med
. 2022 Nov;
42(4):687-704.
PMID: 36368790
No abstract available.
8.
Geno K, Badea A, Lynch K, Jannetto P, Hubbard J, Nerenz R, et al.
J Appl Lab Med
. 2022 Aug;
7(6):1318-1328.
PMID: 36036092
Background: Loperamide (Imodium®), a commonly used anti-diarrheal, is a mu opioid receptor agonist that, like all opioids, reduces gastrointestinal tract peristalsis. Loperamide is considered to have low abuse potential as...
9.
Alvarez Y, Kelliher M, Hubbard J, Nerenz R, Cervinski M
J Appl Lab Med
. 2022 Jul;
7(5):1151-1157.
PMID: 35899580
Background: The aim of this study was to redefine the icterus index cutoff for the Roche Jaffé creatinine method using both conjugated and unconjugated bilirubin on 3 Roche cobas modules...
10.
Toledo D, Robbins A, Gallagher T, Hershberger K, Barney R, Salmela S, et al.
Microbiol Spectr
. 2022 Apr;
10(2):e0220721.
PMID: 35412387
SARS-CoV-2 viral RNA is shed in the stool of 55-70% of infected individuals and can be detected in community wastewater up to 7 days before people present with COVID-19 symptoms....